FOLH1 and prostate carcinoma: To treat prostate cancer cells in spheroids, Alserihi et al. [45] functionalized EGCG-loaded NPs with folic acid to mediate binding to both the human folate receptor alpha (FOLR1) and prostate-specific membrane antigen (PSMA).